FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jacek Capala

Research Profile

Procedures

Chemicals & Drugs

Disorders

Anatomy

Living Beings

Co-author Network

Publications

TOP 3
Gabriela Kramer-Marek; Monika Kuban; Aras Omer; Jurgen Seidel; Rafal Zielinski; Omer Aras; Ulas Bagci; Marcelino Bernardo; Peter Choyke; Dale O Kiesewetter; Jacek Capala
PET of HER2-positive pulmonary metastases with 18F-ZHER2:342 affibody in a murine model of breast cancer: comparison with 18F-FDG.
Moinuddin Hassan; Rafal Zielinski; Yasaman Ardeshirpour; Jacek Capala; Victor Chernomordik; Amir Gandjbakhche
In vivo method to monitor changes in HER2 expression using near-infrared fluorescence imaging.
Gabriela Kramer-Marek; Jacek Capala
The role of nuclear medicine in modern therapy of cancer.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jacek Capala (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Gabriela Kramer-Marek; Monika Kuban; Aras Omer; Jurgen Seidel; Rafal Zielinski; Omer Aras; Ulas Bagci; Marcelino Bernardo; Peter Choyke; Dale O Kiesewetter; Jacek Capala
PET of HER2-positive pulmonary metastases with 18F-ZHER2:342 affibody in a murine model of breast cancer: comparison with 18F-FDG.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2012;53(6):939-46.
2012: Moinuddin Hassan; Rafal Zielinski; Yasaman Ardeshirpour; Jacek Capala; Victor Chernomordik; Amir Gandjbakhche
In vivo method to monitor changes in HER2 expression using near-infrared fluorescence imaging.
Molecular imaging 2012;11(3):177-86.
2012: Gabriela Kramer-Marek; Jacek Capala
The role of nuclear medicine in modern therapy of cancer.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2012;33(3):629-40.
2012: Gabriela Kramer-Marek; Ioannis Roxanis; Rafal Zielinski; Ruth Bennett; Merel Gijsen; Dale O Kiesewetter; Anthony Kong; Jacek Capala
Potential of PET to predict the response to trastuzumab treatment in an ErbB2-positive human xenograft tumor model.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2012;53(4):629-37.
2012: Rafal Zielinski; Yasaman Ardeshirpour; Jacek Capala; Victor Chernomordik; Alejandra Garcia-Glaessner; Moinuddin Hassan; Ilya Lyakhov; Danielle Needle; Amir H Gandjbakhche
Affibody-DyLight conjugates for in vivo assessment of HER2 expression by near-infrared optical imaging.
PloS one 2012;7(7):e41016.
2012: Gabriela Kramer-Marek; Jacek Capala
Can PET imaging facilitate optimization of cancer therapies?
Current pharmaceutical design 2012;18(18):2657-69.
2012: Yasaman Ardeshirpour; Jacek Capala; Victor Chernomordik; Amir H Gandjbakhche; Gary Griffiths; Jay R Knutson; Ilya Lyakhov; Aleksandr V Smirnov; Olga Vasalatiy; Rafal Zielinski; Samuel achilefu; Moinuddin Hassan
In vivo fluorescence lifetime imaging monitors binding of specific probes to cancer biomarkers.
PloS one 2012;7(2):e31881.
2011: Y Ardeshirpour; Jacek Capala; Victor Chernomordik; G Griffiths; M Hassan; P Smith; R Zielinsky; Samuel achilefu; Amir H Gandjbakhche
Using in-vivo fluorescence imaging in personalized cancer diagnostics and therapy, an image and treat paradigm.
Technology in cancer research & treatment 2011;10(6):549-60.
2011: Gabriela Kramer-Marek; Jurgen Seidel; Nalini Shenoy; Peter Choyke; Gary L Griffiths; Jacek Capala
68Ga-DOTA-affibody molecule for in vivo assessment of HER2/neu expression with PET.
European journal of nuclear medicine and molecular imaging 2011;38(11):1967-76.
2011: Malin Dahl; Gabriela Kramer-Marek; Jørgen Nordling; Pierre Bouchelouche; Jacek Capala; Kirsten Bouchelouche
Sarcosine induces increase in HER2/neu expression in androgen-dependent prostate cancer cells.
Molecular biology reports 2011;38(7):4237-43.
2011: Rafal Zielinski; Amir Gandjbakhche; Moinuddin Hassan; Monika Kuban; Ilya Lyakhov; Kimberly Shafer-Weaver; Jacek Capala
HER2-affitoxin: a potent therapeutic agent for the treatment of HER2-overexpressing tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2011;17(15):5071-81.
2011: Brandon Smith; Amichai Yavlovich; Ulrich Baxa; Robert Blumenthal; Jacek Capala; Kristin Loomis; Ilya Lyakhov; Danielle Needle; Anu Puri
Hyperthermia-triggered intracellular delivery of anticancer agent to HER2(+) cells by HER2-specific affibody (ZHER2-GS-Cys)-conjugated thermosensitive liposomes (HER2(+) affisomes).
Journal of controlled release : official journal of the Controlled Release Society 2011;153(2):187-94.
2011: Kirsten Bouchelouche; Scott T Tagawa; Stanley J Goldsmith; Baris Turkbey; Jacek Capala; Peter Choyke
PET/CT Imaging and Radioimmunotherapy of Prostate Cancer.
Seminars in nuclear medicine 2011;41(1):29-44.
2010: Jacek Capala; Kirsten Bouchelouche
Molecular imaging of HER2-positive breast cancer: a step toward an individualized 'image and treat' strategy.
Current opinion in oncology 2010;22(6):559-66.
2010: Rafal J Zielinski; Jeremy V Smedley; Pin-Yu Perera; Peter M Silvera; Thomas A Waldmann; Jacek Capala; Liyanage P Perera
Smallpox vaccine with integrated IL-15 demonstrates enhanced in vivo viral clearance in immunodeficient mice and confers long term protection against a lethal monkeypox challenge in cynomolgus monkeys.
Vaccine 2010;28(43):7081-91.
2010: Victor Chernomordik; Moinuddin Hassan; Sang Bong Lee; Rafal Zielinski; Amir Gandjbakhche; Jacek Capala
Quantitative analysis of Her2 receptor expression in vivo by near-infrared optical imaging.
Molecular imaging 2010;9(4):192-200.
2010: Kirsten Bouchelouche; Baris Turkbey; Peter Choyke; Jacek Capala
Imaging prostate cancer: an update on positron emission tomography and magnetic resonance imaging.
Current urology reports 2010;11(3):180-90.
2010: Kirsten Bouchelouche; Jacek Capala
'Image and treat': an individualized approach to urological tumors.
Current opinion in oncology 2010;22(3):274-80.
2010: Ilya Lyakhov; Rafal Zielinski; Monika Kuban; Gabriela Kramer-Marek; Robert Fisher; Oleg Chertov; Lakshman K Bindu; Jacek Capala
HER2- and EGFR-specific affiprobes: novel recombinant optical probes for cell imaging.
Chembiochem : a European journal of chemical biology 2010;11(3):345-50.
2010: Kirsten Bouchelouche; Peter L Choyke; Jacek Capala
Prostate specific membrane antigen- a target for imaging and therapy with radionuclides.
Discovery medicine 2010;9(44):55-61.
2010: Jie Zheng; David Zhang; Pawel F Przytycki; Rafal Zielinski; Jacek Capala; Teresa M Przytycka
SimBoolNet--a Cytoscape plugin for dynamic simulation of signaling networks.
Bioinformatics (Oxford, England) 2010;26(1):141-2.
2009: Rafal Zielinski; Ilya Lyakhov; Amy Jacobs; Oleg Chertov; Gabriela Kramer-Marek; Nicholas Francella; Andrew Stephen; Robert Fisher; Robert Blumenthal; Jacek Capala
Affitoxin--a novel recombinant, HER2-specific, anticancer agent for targeted therapy of HER2-positive tumors.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2009;32(8):817-25.
2009: Kirsten Bouchelouche; Jacek Capala; Peter Oehr
Positron emission tomography/computed tomography and radioimmunotherapy of prostate cancer.
Current opinion in oncology 2009;21(5):469-74.
2009: Gabriela Kramer-Marek; Dale O Kiesewetter; Jacek Capala
Changes in HER2 expression in breast cancer xenografts after therapy can be quantified using PET and (18)F-labeled affibody molecules.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2009;50(7):1131-9.
2009: Nicole Y Morgan; Gabriela Kramer-Marek; Paul D Smith; Kevin Camphausen; Jacek Capala
Nanoscintillator conjugates as photodynamic therapy-based radiosensitizers: calculation of required physical parameters.
Radiation research 2009;171(2):236-44.
2009: Rafal Zielinski; Pawel F Przytycki; Jie Zheng; David Zhang; Teresa M Przytycka; Jacek Capala
The crosstalk between EGF, IGF, and Insulin cell signaling pathways--computational and experimental analysis.
BMC systems biology 2009;3():88.
2008: Roger Henriksson; Jacek Capala; Annika Michanek; Sten-Ake Lindahl; Leif G Salford; Lars Franzén; Erik Blomquist; Jan-Erik Westlin; A Tommy Bergenheim
Boron neutron capture therapy (BNCT) for glioblastoma multiforme: a phase II study evaluating a prolonged high-dose of boronophenylalanine (BPA).
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2008;88(2):183-91.
2008: Thuy T Koll; Steven S Feis; Mollie H Wright; Modupe M Teniola; Mekel M Richardson; Ana I Robles; John Bradsher; Jacek Capala; Lyuba Varticovski
HSP90 inhibitor, DMAG, synergizes with radiation of lung cancer cells by interfering with base excision and ATM-mediated DNA repair.
Molecular cancer therapeutics 2008;7(7):1985-92.
2008: Sang Bong Lee; Moinuddin Hassan; Robert Fisher; Oleg Chertov; Victor Chernomordik; Gabriela Kramer-Marek; Amir Gandjbakhche; Jacek Capala
Affibody molecules for in vivo characterization of HER2-positive tumors by near-infrared imaging.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(12):3840-9.
2008: Gabriela Kramer-Marek; Dale O Kiesewetter; Lucia Martiniova; Elaine Jagoda; Sang Bong Lee; Jacek Capala
[18F]FBEM-Z(HER2:342)-Affibody molecule-a new molecular tracer for in vivo monitoring of HER2 expression by positron emission tomography.
European journal of nuclear medicine and molecular imaging 2008;35(5):1008-18.
2008: Guang Li; Huchen Xie; Holly Ning; Deborah Citrin; Jacek Capala; Roberto Maass-Moreno; Peter Guion; Barbara C Arora; C Norman Coleman; Kevin A. Camphausen; Guang Li
Accuracy of 3D volumetric image registration based on CT, MR and PET/CT phantom experiments.
Journal of applied clinical medical physics / American College of Medical Physics 2008;9(4):2781.
2008: Anu Puri; Gabriela Kramer-Marek; Ryan Campbell-Massa; Amichai Yavlovich; Shrikant C Tele; Sang-Bong Lee; Jeffrey D Clogston; Anil K Patri; Robert Blumenthal; Jacek Capala
HER2-specific affibody-conjugated thermosensitive liposomes (Affisomes) for improved delivery of anticancer agents.
Journal of liposome research 2008;18(4):293-307.
2007: Moinuddin Hassan; Riley Jason; Victor Chernomordik; Paul Smith; Randall Pursley; Sang Bong Lee; Jacek Capala; Amir H Gandjbakhche
Fluorescence lifetime imaging system for in vivo studies.
Molecular imaging 2007;6(4):229-36.
2005: Peter J Binns; Kent J Riley; Otto K Harling; WS Kiger; Per M Munck af Rosenschöld; Valerio Giusti; Jacek Capala; Kurt Sköld; Iiro Auterinen; Tom Serén; Petri Kotiluoto; Jouni Uusi-Simola; Milan Marek; Ladislav Viererbl; F Spurny
An international dosimetry exchange for boron neutron capture therapy. Part I: Absorbed dose measurements.
Medical physics 2005;32(12):3729-36.
2005: Guang Li; Huchen Xie; Holly Ning; Jacek Capala; Barbara C Arora; C Norman Coleman; Kevin A. Camphausen; Guang Li
A novel 3D volumetric voxel registration technique for volume-view-guided image registration of multiple imaging modalities.
International journal of radiation oncology, biology, physics 2005;63(1):261-73.
2005: Erika Bohl Kullberg; Qichun Wei; Jacek Capala; Valerio Giusti; Per-Uno Malmstrom; Lars Gedda
EGF-receptor targeted liposomes with boronated acridine: growth inhibition of cultured glioma cells after neutron irradiation.
International journal of radiation biology 2005;81(8):621-9.
2005: Deborah Citrin; Holly Ning; Peter Guion; Guang Li; Robert C Susil; Guang Li; Etienne Lessard; Jean Pouliot; Xie Huchen; Jacek Capala; C Norman Coleman; Kevin A. Camphausen; Cynthia Ménard
Inverse treatment planning based on MRI for HDR prostate brachytherapy.
International journal of radiation oncology, biology, physics 2005;61(4):1267-75.
2005: A Tommy Bergenheim; Jacek Capala; Michael Roslin; Roger Henriksson
Distribution of BPA and metabolic assessment in glioblastoma patients during BNCT treatment: a microdialysis study.
Journal of neuro-oncology 2005;71(3):287-93.
2004: Maria Dahlström; Jacek Capala; Peter Lindström; Ake Wasteson; Annelie Lindström
Accumulation of boron in human malignant glioma cells in vitro is cell type dependent.
Journal of neuro-oncology 2004;68(3):199-205.
2004: Per M Munck af Rosenschöld; Jacek Capala; Crister P Ceberg; Valerio Giusti; Leif G Salford; Bertil R R Persson
Quality assurance of patient dosimetry in boron neutron capture therapy.
Acta oncologica (Stockholm, Sweden) 2004;43(4):404-11.
2003: Valerio Giusti; Per M Munck af Rosenschöld; Kurt Sköld; Bruno Montagnini; Jacek Capala
Monte Carlo model of the Studsvik BNCT clinical beam: description and validation.
Medical physics 2003;30(12):3107-17.
2003: Erika Bohl Kullberg; Jörgen Carlsson; Katarina Edwards; Jacek Capala; Stefan Sjöberg; Lars Gedda
Introductory experiments on ligand liposomes as delivery agents for boron neutron capture therapy.
International journal of oncology 2003;23(2):461-7.
2003: Per M Munck af Rosenschöld; Valerio Giusti; Crister P Ceberg; Jacek Capala; Kurt Sköld; Bertil R R Persson
Reference dosimetry at the neutron capture therapy facility at Studsvik.
Medical physics 2003;30(7):1569-79.
2003: Jacek Capala; Britta H Stenstam; Kurt Sköld; Per Munck af Rosenschöld; Valerio Giusti; Charlotta Persson; Eva Wallin; Arne Brun; Lars Franzen; Jörgen Carlsson; Leif G Salford; Crister P Ceberg; Bertil Persson; Luigi Pellettieri; Roger Henriksson
Boron neutron capture therapy for glioblastoma multiforme: clinical studies in Sweden.
Journal of neuro-oncology 2003;62(1-2):135-44.
2003: Jörgen Carlsson; Erika Bohl Kullberg; Jacek Capala; Stefan Sjöberg; Katarina Edwards; Lars Gedda
Ligand liposomes and boron neutron capture therapy.
Journal of neuro-oncology 2003;62(1-2):47-59.
2002: Eva Svantesson; Jacek Capala; Karin E Markides; Jean Pettersson
Determination of boron-containing compounds in urine and blood plasma from boron neutron capture therapy patients. The importance of using coupled techniques.
Analytical chemistry 2002;74(20):5358-63.
2000: Lucian Wielopolski; Jacek Capala; N E Pendzick; AD Chanana
Patient positioning in static beams for boron neutron capture therapy of malignant glioma.
Radiation medicine 2000;18(6):381-7.
2000: Jeffrey A Coderre; P R Gavin; Jacek Capala; R Ma; Gerard M Morris; Terry M Button; T Aziz; NS Peress
Tolerance of the normal canine brain to epithermal neutron irradiation in the presence of p-boronophenylalanine.
Journal of neuro-oncology 2000;48(1):27-40.
2000: T Aziz; NS Peress; A Diaz; Jacek Capala; AD Chanana
Postmortem neuropathological features secondary to boron neutron capture therapy for glioblastoma multiforme.
Journal of neuropathology and experimental neurology 2000;59(1):62-73.
1999: F J Wheeler; David W Nigg; Jacek Capala; P R Watkins; C Vroegindeweij; Iiro Auterinen; Tiina Seppälä; D Bleuel
Boron neutron capture therapy (BNCT): implications of neutron beam and boron compound characteristics.
Medical physics 1999;26(7):1237-44.
1999: PD Bradley; Anatoly Rosenfeld; B Allen; Jeffrey A Coderre; Jacek Capala
Performance of silicon microdosimetry detectors in boron neutron capture therapy.
Radiation research 1999;151(3):235-43.
1998: Manjeet Chadha; Jacek Capala; Jeffrey A Coderre; Eric Elowitz; J Iwai; DD Joel; H B Liu; Lucian Wielopolski; AD Chanana
Boron neutron-capture therapy (BNCT) for glioblastoma multiforme (GBM) using the epithermal neutron beam at the Brookhaven National Laboratory.
International journal of radiation oncology, biology, physics 1998;40(4):829-34.
1998: Pär Olsson; M Black; Jacek Capala; Jeffrey A Coderre; T Hartman; M Makar; J Malmquist; Jean Pettersson; Nina Tilly; Stefan Sjöberg; Jörgen Carlsson
Uptake, toxicity and radiation effects of the boron compounds DAAC-1 and DAC-1 in cultured human glioma cells.
International journal of radiation biology 1998;73(1):103-12.
1997: Jeffrey A Coderre; Eric Elowitz; Manjeet Chadha; R Bergland; Jacek Capala; DD Joel; H B Liu; Daniel N Slatkin; AD Chanana
Boron neutron capture therapy for glioblastoma multiforme using p-boronophenylalanine and epithermal neutrons: trial design and early clinical results.
Journal of neuro-oncology 1997;33(1-2):141-52.
1997: David W Nigg; F J Wheeler; Daniel E Wessol; Jacek Capala; Manjeet Chadha
Computational dosimetry and treatment planning for boron neutron capture therapy.
Journal of neuro-oncology 1997;33(1-2):93-104.
1997: Gerard M Morris; Jeffrey A Coderre; Peggy L Micca; CD Fisher; Jacek Capala; John W Hopewell
Central nervous system tolerance to boron neutron capture therapy with p-boronophenylalanine.
British journal of cancer 1997;76(12):1623-9.
1996: H B Liu; D D Greenberg; Jacek Capala; F J Wheeler
An improved neutron collimator for brain tumor irradiations in clinical boron neutron capture therapy.
Medical physics 1996;23(12):2051-60.
1996: Jacek Capala; M S Makar; Jeffrey A Coderre
Accumulation of boron in malignant and normal cells incubated in vitro with boronophenylalanine, mercaptoborane or boric acid.
Radiation research 1996;146(5):554-60.
1996: C Grönvik; Jacek Capala; Jörgen Carlsson
The non-variation in radiosensitivity of different proliferative states of human glioma cells.
Anticancer research 1996;16(1):25-31.
1994: Jacek Capala; Helmut Acker; Anton Lindström; Jörgen Carlsson
Effects of epidermal growth factor receptor blocking in cultured glioma spheroids.
Anticancer research 1994;14(1A):45-53.
1992: A Andersson; Jacek Capala; Jörgen Carlsson
Effects of EGF-dextran-tyrosine-131I conjugates on the clonogenic survival of cultured glioma cells.
Journal of neuro-oncology 1992;14(3):213-23.
1991: Jacek Capala; Jörgen Carlsson
Influence of chloroquine and lidocaine on retention and cytotoxic effects of [131I]EGF: studies on cultured glioma cells.
International journal of radiation biology 1991;60(3):497-510.
1991: S Scott-Robson; Jacek Capala; Jörgen Carlsson; P Malmborg; Hans Lundqvist
Distribution and stability in the rat of a 76Br/125I-labelled polypeptide, epidermal growth factor.
International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology 1991;18(2):241-6.
1991: S Scott-Robson; Jacek Capala; P Malmborg; Hans Lundqvist
Production of 76Br and its use in labeling proteins.
Acta radiologica. Supplementum 1991;376():64.
1990: Jacek Capala; M Pråhl; S Scott-Robson; J Pontén; B Westermark; Jörgen Carlsson
Effects of 131I-EGF on cultured human glioma cells.
Journal of neuro-oncology 1990;9(3):201-10.